These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 11299838)
1. Characteristics of cystic breast disease with special regard to breast cancer development. Budai B; Számel I; Sulyok Z; Német M; Bak M; Ottó S; Reed MJ; Purohit A; Parish DC; Kralovánszky J Anticancer Res; 2001; 21(1B):749-52. PubMed ID: 11299838 [TBL] [Abstract][Full Text] [Related]
2. Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer risk. Budai B; Számel I; Sulyok Z; Németh M; Bak M; Kralovánszky J; Ottó S; Besznyák I; Purohit A; Parish DC; Reed MJ Anticancer Res; 2000; 20(5C):3879-86. PubMed ID: 11268470 [TBL] [Abstract][Full Text] [Related]
3. Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast. Naldoni C; Costantini M; Dogliotti L; Bruzzi P; Bucchi L; Buzzi G; Torta M; Angeli A Cancer Res; 1992 Apr; 52(7):1791-5. PubMed ID: 1551110 [TBL] [Abstract][Full Text] [Related]
4. The epidemiology of gross cystic disease of the breast confirmed by biopsy or by aspiration of cyst fluid. Bodian CA; lattes R; Perzin KH Cancer Detect Prev; 1992; 16(1):7-15. PubMed ID: 1551140 [TBL] [Abstract][Full Text] [Related]
5. Steroid and cation correlations in human breast cyst fluid: preliminary findings. Levitz M; Raju U; Boccardo F; Arcuri F; Castagnetta L Cancer Detect Prev; 1992; 16(1):57-9. PubMed ID: 1532348 [TBL] [Abstract][Full Text] [Related]
6. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045 [TBL] [Abstract][Full Text] [Related]
7. Biochemical analysis of breast cyst fluid as a possible predictor of breast carcinoma development. Simíøcková M; Pecen L; Eben K; Nekulová M; Vermousek I; Stratil P; Rejthar A; Cernoch M; Lang B; Sakalová J Neoplasma; 1994; 41(5):245-52. PubMed ID: 7854493 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content. Boccardo F; Valenti G; Zanardi S; Cerruti G; Fassio T; Bruzzi P; De Franchis V; Barreca A; Del Monte P; Minuto F Cancer Res; 1988 Oct; 48(20):5860-3. PubMed ID: 2971432 [TBL] [Abstract][Full Text] [Related]
9. Cohort study of women affected by gross cystic disease. Correlation between cationic and hormonal composition of breast cyst fluid and the risk of breast cancer. Naldoni C; Bruzzi P; Bucchi L; Gordini S; Torta M; Caraci P; Orlandi F Ann N Y Acad Sci; 1990; 586():272-5. PubMed ID: 2357007 [No Abstract] [Full Text] [Related]
10. [Prevalence of tumors in the left breast]. Aareleĭd TP; Khint EK Vopr Onkol; 1987; 33(5):37-42. PubMed ID: 3590667 [TBL] [Abstract][Full Text] [Related]
11. Serum sex hormones and breast cancer risk factors in postmenopausal women. Lamar CA; Dorgan JF; Longcope C; Stanczyk FZ; Falk RT; Stephenson HE Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):380-3. PubMed ID: 12692114 [TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor-alpha and interleukin-1 and -6 in fibrocystic breast disease. Herruzo A; Castilla JA; Ramírez A; Marcos C; Menjón S Breast Cancer Res Treat; 1999 Mar; 54(2):159-64. PubMed ID: 10424406 [TBL] [Abstract][Full Text] [Related]
13. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus. Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516 [TBL] [Abstract][Full Text] [Related]
14. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642 [TBL] [Abstract][Full Text] [Related]
15. [Hormone risk factors during breast tumoral promotion, progression and prognosis]. Esquivel EL; López AP; Sánchez LC Ginecol Obstet Mex; 2004 Nov; 72():545-9. PubMed ID: 15986762 [TBL] [Abstract][Full Text] [Related]
16. Benign breast diseases: risk factor or precancerous state? Gerber M Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():113-8. PubMed ID: 8298440 [No Abstract] [Full Text] [Related]
17. Role and impact of menstrual and reproductive factors on breast cancer risk in Japan. Iwasaki M; Otani T; Inoue M; Sasazuki S; Tsugane S; Eur J Cancer Prev; 2007 Apr; 16(2):116-23. PubMed ID: 17297387 [TBL] [Abstract][Full Text] [Related]
18. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones. Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882 [TBL] [Abstract][Full Text] [Related]
19. Use of oral contraceptives, alcohol, and risk for invasive breast cancer. Dumeaux V; Lund E; Hjartåker A Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1302-7. PubMed ID: 15298950 [TBL] [Abstract][Full Text] [Related]
20. [Is fibrocystic disease precancerous?]. De León Antoni E Bol Asoc Med P R; 1989 Nov; 81(11):451-4. PubMed ID: 2690835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]